Europe Telemedicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

The European telemedicine market is expected to register a CAGR of 5.48% over the forecast period.

During the COVID-19 pandemic, telemedicine, or telehealth, emerged as a critical component of healthcare. The adoption of digital health has accelerated in countries all over the world, not just in Europe.According to WHO, in October 2022, telemedicine technologies will have benefited from the screening, diagnosis, management, therapy, and long-term follow-up of a number of chronic diseases in the WHO European Region. Countries primarily relied on digital technologies to continue offering patients crucial medical care during the COVID-19 epidemic. The use of telemedicine was previously recognized as a practical and affordable strategy for providing high-quality care and lowering overall morbidity and mortality. This has been the primary driver of the market's growth in the period studied.

Rising healthcare expenditure, an increasing preference for remote patient monitoring, and the rising burden of chronic diseases are the factors propelling market growth in this region. For example, the Statista Research Department estimates that in 2020, Germany spent 12.5% of its GDP on healthcare.Similarly, according to an article published by the Peter G. Peterson Foundation, in 2021, Germany was the second highest-spending country with about USD 7,383 in healthcare costs per capita, while the average for wealthy OECD countries, excluding the United States, was only USD 5,829 per person.

In September 2021, the European Union (EU), four UN agencies (WHO, UNFPA, UNICEF, and UNOPS), and Georgia's Ministry of IDPs from Occupied Territories, Labor, Health, and Social Affairs launched a new telemedicine initiative aimed at reducing the impact of the COVID-19 pandemic in the country. In September 2021, the Faculty of Sexual and Reproductive Healthcare (FSRH) and the Royal College of Obstetricians and Gynecologists (RCOG) worked together to start a new campaign to spread information about telemedicine for early medical abortion (EMA).

Thus, the abovementioned factors are impacting the market growth of the European telemedicine market. However, several legal and reimbursement issues, high initial capital requirements, and a lack of physician support are expected to be the major restraints on market growth. ​

Europe Telemedicine Market Trends

mHealth Expected to be the Fastest-growing Segment over the Forecast Period

During the COVID-19 pandemic, mHealth emerged as the most important asset for keeping track of health. The use of mobile health applications increased in the region. mHealth applications are also being promoted by a number of regulatory bodies in Europe. The European National Institute for Health and Disability Insurance (INAMI-RIZIV) launched a pilot project in December 2020 to monitor COVID-19 patients remotely before and after their hospitalization as part of an integrated medical approach supported by digital applications. In general, the COVID-19 pandemic had a positive impact on market growth. Rapid advancements in mobile wireless communications and wearable sensor technology may close the gap between home- and centre-based delivery models by combining availability, accessibility, and adaptive, personalized clinical monitoring. Therefore, remote patient monitoring with telemedicine is gaining attention across healthcare facilities.

Furthermore, the rise of chronic diseases is a major concern that strains healthcare resources. According to the 2022 statistics published by National Health Science, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2020-2021, accounting for 1.9% of the total population. Moreover, according to the British Heart Foundation England Factsheet, published in January 2022, about 6.4 million people are living with cardiovascular diseases in England. The British Heart Foundation 2020 fact sheet stated that around 7.4 million people are living with heart and circulatory diseases in the United Kingdom. Similarly, as per the September 2021 update by the National Health Service, more than 2 million people in the United Kingdom experience arrhythmias or heart rhythm problems. Therefore, the increasing number of heart problems is expected to increase the need for early detection and treatment. mHealth is a cutting-edge method of providing care, monitoring a patient, and disseminating information. Monitoring allows for the early detection of diseases and the prevention of chronic illnesses. The potential advantages have led to the increasing adoption of mHealth technologies, and players in this region are coming up with innovative launches to further increase mHealth's adaptability in this region. For instance, in early January 2021, the Rehappy health app was launched by the DiGA directory of digital health applications for stroke patients in Germany. Thus, the increasing chronic disease with a increase number of development by market players, coupled with rising initiatives by the government for mHealth, are expected to propel the growth of this segment.

Germany is Expected to Dominate the Europe Telemedicine Market Over the Forecast Period

Telemedicine is a rapidly growing component of healthcare in Germany due to the high healthcare expenditure, increase in chronic disease, and rise in the geriatric population. The adoption of telemedicine has improved care management, patients’ quality of life, and reduced healthcare spending. According to the report published by Organization for Economic Cooperation and Development (OECD), in 2022, the median age in Germany is expected to rise from 45.7 years in 2020 to 49.2 years by 2045. Thus, while Germany is already a rather old country, its population is aging at a fast pace. Furthermore, according to Statista Research Department, in June 2022, Germany spent 12.5% of its GDP on healthcare in 2020. In addition, the increasing geriatric population will likely increase market growth over the forecast period. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Germany, a large proportion of the population is estimated to be aged 15-64 years, accounting for 64% in 2022. In addition, according to the same source, 22% of the population will be 65 years and above in 2022. Thus, the expected increase in the geriatric population being more prone to chronic diseases will increase the demand for telemedicine, thereby boosting the market growth.

Additionally, vendors are engaged in partnerships, collaborations, acquisitions, mergers, and product launches to sustain in the market. For instance, in March 2022, MedX Health and Health Partners formed a strategic partnership to launch MedX's Teledermatology Screening Platform in the United Kingdom.

Thus, given the aforementioned factors, the telemedicine market is expected to grow significantly in North America over the forecast period.

Europe Telemedicine Market Competitor Analysis

The European telemedicine market is moderate in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market shares and are well known, including Aerotel Medical Systems (1998) Ltd., Allscripts Healthcare Solutions Inc., AMD Global Telemedicine Inc., OTH.IO., and International Business Machinery Corporation (IBM), among others.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.